Maternal antigen presenting cells are a source of plasmatic HLA-G during pregnancy:: Longitudinal study during pregnancy

被引:55
作者
Alegre, Estibaliz
Diaz-Lagares, Angel
LeMaoult, Joel
Lopez-Moratalla, Natalia
Carosella, Edgardo D.
Gonzalez, Alvaro [1 ]
机构
[1] Univ Navarra Clin, Dept Biochem, Pamplona, Spain
[2] Univ Navarra, Dept Biochem, Pamplona, Spain
[3] Hop St Louis, Inst Univ Hematol, CEA DSV DRM, Serv Rech Hemato Immunol, Paris, France
关键词
abortion; dendritic cells; HLA-G; monocytes; pregnancy;
D O I
10.1016/j.humimm.2007.04.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The aim of this work was to investigate the longitudinal evolution of plasmatic soluble HLA-G (sHLA-G: shed HLA-G1 plus HLA-G5) during pregnancy, and if peripheral maternal antigen presenting cells (APC) can be a source of sHLA-G. Blood samples were obtained from 45 volunteers during normal pregnancy, 8 of them monthly; from 8 pregnant volunteers in the first weeks of pregnancy who had later a miscarriage, and from 14 healthy nonpregnant control women. Monocytes obtained during pregnancy showed a moderately HLA-G cell surface expression and stimulation with interferon (IFN)-gamma increased this expression. Monocytes-derived dendritic cells obtained from pregnant women during the first and third trimester of pregnancy secreted more sHLA-G than those obtained from nonpregnant women. Plasmatic sHLA-G concentration in pregnant women was significatively higher than in nonpregnant women, with a peak in the third month. We can conclude that maternal APC are a source of sHLA-G. Women who experienced miscarriage had previously very tow or undetectable plasmatic sHLA-G Levels in the second month of pregnancy. Data suggest that undetectable sHLA-G could be a risk of complications. (c) 2007 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc.
引用
收藏
页码:661 / 667
页数:7
相关论文
共 45 条
  • [31] Determination of soluble HLA-G and HLA-A, -B, and -C molecules in pregnancy
    Puppo, F
    Costa, M
    Contini, P
    Brenci, S
    Cevasco, E
    Ghio, M
    Norelli, R
    Bensussan, A
    Capitanio, GL
    Indiveri, F
    [J]. TRANSPLANTATION PROCEEDINGS, 1999, 31 (04) : 1841 - 1843
  • [32] Association of soluble HLA-G plasma levels with HLA-G alleles
    Rebmann, V
    van der Ven, K
    Pässler, M
    Pfeiffer, K
    Krebs, D
    Grosse-Wilde, H
    [J]. TISSUE ANTIGENS, 2001, 57 (01): : 15 - 21
  • [33] Report of the Wet Workshop for Quantification of soluble HLA-G in Essen, 2004
    Rebmann, V
    LeMaoult, J
    Rouas-Freiss, N
    Carosella, ED
    Grosse-Wilde, H
    [J]. HUMAN IMMUNOLOGY, 2005, 66 (08) : 853 - 863
  • [34] Detection of soluble HLA-G molecules in plasma and amniotic fluid
    Rebmann, V
    Pfeiffer, K
    Pässler, M
    Ferrone, S
    Maier, S
    Weiss, E
    Grosse-Wilde, H
    [J]. TISSUE ANTIGENS, 1999, 53 (01): : 14 - 22
  • [35] Tolerization of dendritic cells by HLA-G
    Ristich, V
    Liang, SY
    Zhang, W
    Wu, J
    Horuzsko, A
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (04) : 1133 - 1142
  • [36] Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis
    RouasFreiss, N
    Goncalves, RMB
    Menier, C
    Dausset, J
    Carosella, ED
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (21) : 11520 - 11525
  • [37] HLA-G levels in serum and plasma
    Rudstein-Svetlicky, N
    Loewenthal, R
    Horejsi, V
    Gazit, E
    [J]. TISSUE ANTIGENS, 2006, 67 (02): : 111 - 116
  • [38] Solier C, 2002, EUR J IMMUNOL, V32, P3576, DOI 10.1002/1521-4141(200212)32:12<3576::AID-IMMU3576>3.0.CO
  • [39] 2-M
  • [40] Placental abruption is associated with decreased maternal plasma levels of soluble HLA-G
    Steinborn, A
    Rebmann, V
    Scharf, A
    Sohn, C
    Grosse-Wilde, H
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2003, 23 (04) : 307 - 314